A Roadmap for Curing Cancer, Alzheimer's, and Cardiovascular Disease

ISBN-13: 9780128127964 / Angielski / Miękka / 2017 / 160 str.

Paul J. Marangos

Spis treści

Part A. The Reasons for Failure1. The Medical R&D Fiasco2. Academia Is Marching to the Wrong Drummer3. Mavericks Versus the Establishment4. The Strangled Unincentivized Drug Industry5. The FDA Roadblock to Cures6. The Liability Barrier

Part B. Towards Solutions7. Cleaning Up the Academic Research Quagmire8. Reforming the FDA9. Enabling the Drug Industry10. Patent and Liability Reform11. The Public Will Make It Happen

O autorze

Dr. Marangos is author of 252 peer-reviewed research papers on neurobiology, and 4 books - three by Academic Press (the Neurobiological Research series of volumes) and a fourth titled "Emerging Strategies in Neuroprotection”. He is a founding editor of "The Journal of Molecular Neuroscience” and inventor on 14 issued patents. He spent 13 years at the NIMH and was adjunct professor of neurochemistry at GW School of Medicine during that time. He is co-Founder of five Biotech firms with over 20 years of experience as CEO of both public and private life science companies. He has had extensive experience in all aspects of the pharmaceutical and biotechnology industries from bench to product. This coupled with his academic experience has provided a global perspective on the entire medical R&D enterprise, in particular its faults, and remedies to speed the quest for cures.

https://www.wsj.com/articles/the-terminally-ill-need-more-than-the-right-to-try-1534200199?mod=searchresults&page=1&pos=1

https://www.prnewswire.com/news-releases/biomedica-partners-proposes-the-terminal-disease-act-300609691.html?tc=eml_cleartime

http://thehill.com/opinion/healthcare/383484-right-to-try-efforts-have-have-been-timid-and-poorly-conceived

https://www.prnewswire.com/news-releases/biomedica-partners-presents-major-reforms-in-terminal-disease-drug-development-at-magis-clinical-research-conference-300642731.html